Home
World Journal of Advanced Research and Reviews
International Journal with High Impact Factor for fast publication of Research and Review articles

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

eISSN: 2581-9615 || CODEN: WJARAI || Impact Factor 8.2 ||  CrossRef DOI

Research and review articles are invited for publication in March 2026 (Volume 29, Issue 3) Submit manuscript

Real World Outcomes of Combined MSC Therapy and Functional Medicine in Autism: Early Functional and Behavioral Improvements

Breadcrumb

  • Home
  • Real World Outcomes of Combined MSC Therapy and Functional Medicine in Autism: Early Functional and Behavioral Improvements

M. Mojibul Haque 1, 2, Abdullah Al Noman 1 and Syeda Shayan Zehra 2, *

1 American Wellness Centre, Dhaka, Bangladesh.

2 The Center of Integrative Medicine, Texas, USA.

Research Article

World Journal of Advanced Research and Reviews, 2025, 28(03), 1113-1126

Article DOI: 10.30574/wjarr.2025.28.3.4160

DOI url: https://doi.org/10.30574/wjarr.2025.28.3.4160

Received 01 November 2025; revised on 12 December 2025; accepted on 16 December 2025

Background: Stem cell–based therapy has gained increasing attention as a regenerative approach for neurodevelopmental and functional disorders. While global research supports the therapeutic potential of mesenchymal stem cells (MSCs), early clinical outcomes remain variable, and American cohort data are limited. This hybrid clinical‑trial study integrates empirical findings from 34 U.S. patients with a mechanistic scientific review to evaluate early functional and behavioral outcomes following MSC therapy.

Methods: Thirty‑four patients aged 4–30 years received MSC therapy using standardized cell quantities (15M, 50M, 100M) and four dosing intensities (Dose 1–4). Clinical outcomes were assessed across eight domains: digestion, toilet habits, sleep, hyperactivity, speech, communication, appetite, and overall improvement. Descriptive statistics, dose–response comparisons, and age‑group analyses were performed. Mechanistic interpretation was integrated using established MSC literature.

Results: Functional improvements appeared earlier and more frequently than developmental outcomes. Toilet habits improved in of patients, followed by hyperactivity reduction , digestion , and sleep . Speech and communication improved in  each. Dose 3 demonstrated the highest improvement rate , and younger patients showed significantly greater responsiveness than adolescents or adults. Half the cohort exhibited no early improvement, consistent with expected MSC timelines.

Conclusion: Early findings suggest that MSC therapy may yield meaningful functional improvements in younger American patients, particularly at moderate‑to‑high dosing levels. The integration of empirical data with mechanistic insights highlights the therapeutic potential of MSCs while emphasizing the need for larger controlled studies in the United States. These findings should be interpreted cautiously due to the small sample size and early follow‑up window.

Mesenchymal Stem Cells; Autism; Neurodevelopment; Functional Outcomes; Regenerative Medicine; Clinical Trial; United States Cohort

https://wjarr.com/sites/default/files/fulltext_pdf/WJARR-2025-4160.pdf

Preview Article PDF

M. Mojibul Haque, Abdullah Al Noman and Syeda Shayan Zehra. Real World Outcomes of Combined MSC Therapy and Functional Medicine in Autism: Early Functional and Behavioral Improvements. World Journal of Advanced Research and Reviews, 2025, 28(3), 1113-1126. Article DOI: https://doi.org/10.30574/wjarr.2025.28.3.4160

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 World Journal of Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution